Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s share price reached a new 52-week low on Wednesday . The stock traded as low as C$0.16 and last traded at C$0.17, with a volume of 77287 shares. The stock had previously closed at C$0.17.
Nanalysis Scientific Stock Performance
The stock has a market capitalization of C$18.95 million, a PE ratio of -1.65 and a beta of -0.91. The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The business’s fifty day moving average is C$0.19 and its 200-day moving average is C$0.22.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Recommended Stories
- Five stocks we like better than Nanalysis Scientific
- 3 Fintech Stocks With Good 2021 Prospects
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Airline Stocks – Top Airline Stocks to Buy Now
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- How to Buy Gold Stock and Invest in Gold
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
